December 9, 2015


Controversial Pharmaceutical CEO Buys Wu-Tang Clan $2 Million Album

Isaiah Trickey/FilmMagic
Isaiah Trickey/FilmMagic

Bloomberg Businessweek has published a long piece trailing the saga of Wu-Tang Clan’s Once Upon a Time in Shaolin, the one-of-a-kind record that sold for $2 million. The album sold at the end of November to a then-unknown “private American collector.” A large amount of the money was donated to charity, which is a great thing, considering the buyer.

Under a header image shouting "YOUNG DIRTY BASTARD," the magazine reveals the LP went to Turing Pharmaceuticals CEO Martin Shkreli, a 32-year-old who “seems much younger, with a tendency to fiddle with his hair and squirm in his seat like an adolescent.” Shkreli became infamous in September for jacking the price of Daraprim, an antiparisitc drug used to treat AIDS, up from $13.50 per pill to $750.

“I was a little worried that they were going to walk out of the deal,” Shkreli tells Bloomberg Businessweek of his concerns about Wu-Tang’s reaction to the Daraprim story. “But by then we’d closed. The whole kind of thing since then has been just kind of ‘Well, do we want to announce it’s him? Do we not want to announce it’s him?’ I think they were trying to cover their butts a little bit.”

The full story about the unprecedented album is fascinating. Read it here.